JP2017531678A5 - - Google Patents

Download PDF

Info

Publication number
JP2017531678A5
JP2017531678A5 JP2017522086A JP2017522086A JP2017531678A5 JP 2017531678 A5 JP2017531678 A5 JP 2017531678A5 JP 2017522086 A JP2017522086 A JP 2017522086A JP 2017522086 A JP2017522086 A JP 2017522086A JP 2017531678 A5 JP2017531678 A5 JP 2017531678A5
Authority
JP
Japan
Prior art keywords
group
alkyl
substituted
groups
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017522086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017531678A (ja
JP6616412B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/074431 external-priority patent/WO2016062790A1/en
Publication of JP2017531678A publication Critical patent/JP2017531678A/ja
Publication of JP2017531678A5 publication Critical patent/JP2017531678A5/ja
Application granted granted Critical
Publication of JP6616412B2 publication Critical patent/JP6616412B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017522086A 2014-10-23 2015-10-22 Nik阻害剤としての新規のピラゾロピリミジン誘導体 Expired - Fee Related JP6616412B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14190073 2014-10-23
EP14190073.8 2014-10-23
PCT/EP2015/074431 WO2016062790A1 (en) 2014-10-23 2015-10-22 New pyrazolopyrimidine derivatives as nik inhibitors

Publications (3)

Publication Number Publication Date
JP2017531678A JP2017531678A (ja) 2017-10-26
JP2017531678A5 true JP2017531678A5 (enExample) 2019-11-21
JP6616412B2 JP6616412B2 (ja) 2019-12-04

Family

ID=51846471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017522086A Expired - Fee Related JP6616412B2 (ja) 2014-10-23 2015-10-22 Nik阻害剤としての新規のピラゾロピリミジン誘導体

Country Status (13)

Country Link
US (2) US10221180B2 (enExample)
EP (1) EP3209663B1 (enExample)
JP (1) JP6616412B2 (enExample)
KR (1) KR102523405B1 (enExample)
CN (1) CN107074882B (enExample)
AU (1) AU2015334915B2 (enExample)
BR (1) BR112017007704B1 (enExample)
CA (1) CA2960574C (enExample)
EA (1) EA033237B1 (enExample)
ES (1) ES2715104T3 (enExample)
IL (1) IL251778B (enExample)
MX (1) MX371152B (enExample)
WO (1) WO2016062790A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI663166B (zh) 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
EA033237B1 (ru) 2014-10-23 2019-09-30 Янссен Фармацевтика Нв Новые производные пиразолопиримидина в качестве ингибиторов nik, фармацевтическая композиция и лекарственное средство, содержащее ее
WO2016062792A1 (en) 2014-10-23 2016-04-28 Janssen Pharmaceutica Nv New compounds as nik inhibitors
AU2015334914B2 (en) 2014-10-23 2019-09-19 Janssen Pharmaceutica Nv New thienopyrimidine derivatives as NIK inhibitors
JP6616411B2 (ja) 2014-10-23 2019-12-04 ヤンセン ファーマシューティカ エヌ.ベー. 新規な、nik阻害剤としてのピラゾール誘導体
JP7478142B2 (ja) 2018-06-07 2024-05-02 ディスアーム セラピューティクス, インコーポレイテッド Sarm1阻害剤
AU2019289223B2 (en) * 2018-06-18 2023-09-21 Janssen Pharmaceutica Nv Pyrazole derivatives as MALT1 inhibitors
CA3123215C (en) 2018-12-19 2024-04-02 Disarm Therapeutics, Inc. Inhibitors of sarm1 in combination with neuroprotective agents
US20220162206A1 (en) * 2019-03-29 2022-05-26 Kowa Company, Ltd. Novel azaindole derivative
CR20210587A (es) 2019-05-31 2022-02-11 Janssen Pharmaceutica Nv Inhibidores de molécula pequeña de quinasa inductora de nf-kb

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007926A1 (en) * 1989-01-20 1990-07-26 Pfizer Inc. 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines
BRPI0510319A (pt) 2004-04-26 2007-10-16 Pfizer inibidores da enzima integrase de hiv
TW200736260A (en) 2005-11-10 2007-10-01 Smithkline Beecham Corp Inhibitors of Akt activity
DE102008005493A1 (de) 2008-01-22 2009-07-23 Merck Patent Gmbh 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate
AU2009263037B2 (en) * 2008-06-26 2011-10-06 Amgen Inc. Alkynyl alcohols as kinase inhibitors
CA2728559A1 (en) 2008-07-03 2010-01-07 Exelixis Inc. Cdk modulators
WO2010042337A1 (en) 2008-10-07 2010-04-15 Merck Sharp & Dohme Corp. Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
CN101723936B (zh) 2008-10-27 2014-01-15 上海睿星基因技术有限公司 激酶抑制剂及其在药学中的用途
WO2011050245A1 (en) 2009-10-23 2011-04-28 Yangbo Feng Bicyclic heteroaryls as kinase inhibitors
AR085908A1 (es) * 2011-03-16 2013-11-06 Hoffmann La Roche DERIVADOS DE 3-BUTIN-2-OL Y DE CARBONITRILO CON ACTIVIDAD INHIBIDORA DE LA QUINASA INDUCTORA DE NF-kB (NIK)
TWI663166B (zh) * 2013-04-24 2019-06-21 健生藥品公司 新化合物
TWI627173B (zh) 2013-09-26 2018-06-21 比利時商健生藥品公司 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物
TWI704146B (zh) 2013-09-26 2020-09-11 比利時商健生藥品公司 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物
AU2015334914B2 (en) 2014-10-23 2019-09-19 Janssen Pharmaceutica Nv New thienopyrimidine derivatives as NIK inhibitors
JP6616411B2 (ja) 2014-10-23 2019-12-04 ヤンセン ファーマシューティカ エヌ.ベー. 新規な、nik阻害剤としてのピラゾール誘導体
WO2016062792A1 (en) 2014-10-23 2016-04-28 Janssen Pharmaceutica Nv New compounds as nik inhibitors
EA033237B1 (ru) 2014-10-23 2019-09-30 Янссен Фармацевтика Нв Новые производные пиразолопиримидина в качестве ингибиторов nik, фармацевтическая композиция и лекарственное средство, содержащее ее

Similar Documents

Publication Publication Date Title
AU2014233414B2 (en) N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
JP2017531677A5 (enExample)
JP2016531868A5 (enExample)
JP2019094345A5 (enExample)
JP2019524883A5 (enExample)
US20170157134A1 (en) Combination therapy
FI3658148T3 (fi) Makrosyklisiä yhdisteitä ja niiden käyttöjä
JP2016537366A5 (enExample)
JP2020169187A (ja) 僧帽弁疾患による無症候性心不全の患者の心臓サイズの減少及び/又は臨床的症候の発生の遅延のためのピモベンダンの使用
JP2010524932A5 (enExample)
JP2016531858A5 (enExample)
JP2014037426A5 (enExample)
JP2012510458A5 (enExample)
JP2015503540A5 (enExample)
JP2019515884A5 (enExample)
WO2009082818A8 (en) Novel c-21-keto lupane derivatives preparation and use thereof
JP2014506582A5 (enExample)
JP2015519322A5 (enExample)
JP2024507414A (ja) ウイルス感染症治療のためのrock2阻害剤
JOP20170197A1 (ar) الصيغة الجديدة التي تشتمل على مشتق بنزيميدازول
RU2007103831A (ru) Производные пиразола
US11219633B2 (en) Nucleobase analogue derivatives and their applications
RU2015155032A (ru) Тилозиновые производные и способ их получения
MX2010013978A (es) Derivados de 5-(4-metanosulfonilfenil)tiazol para el tratamiento de enfermedades inflamatorias agudas y cronicas.
JP2015524835A5 (enExample)